☆ 4.7 Editorial Material

ANA Investigates: Neurological Complications of COVID-19 Vaccines

ANNALS OF NEUROLOGY (2021)

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021

Julianne Gee et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Review Clinical Neurology

Effects of MS disease-modifying therapies on responses to vaccinations: A review

John Robert Ciotti et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

添加到收藏夹

News Item Multidisciplinary Sciences

US AUTHORIZATION OF COVID VACCINE MARKS NEW PHASE IN SAFETY MONITORING

Heidi Ledford

NATURE (2020)

添加到收藏夹

ANA Investigates: Neurological Complications of COVID-19 Vaccines

相关参考文献

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021

Effects of MS disease-modifying therapies on responses to vaccinations: A review

US AUTHORIZATION OF COVID VACCINE MARKS NEW PHASE IN SAFETY MONITORING

导出引文

分享论文